TP53 and cancer: Interestingly, the treatment with AuNPs was able to effectively reduce cell viability in PANC-1 and MDA-MB-231 mutant p53 cells by approximately 25%, whereas it did not show a significant effect on MCF-7 cancer cells (Figure 4A–C).